Kiyatec’s Senior Research Scientist, Katy Lassahn, MSc will present new insights at SITC 2022 in Boston: “Detecting T-cell Reinvigoration and Persistence Using Patient-derived ex vivo 3-dimensional spheroid models” featuring our tissue-agnostic ex vivo three-dimensional platform which recapitulates the tumor microenvironment for the assessment of T-cell performance — allows for testing of patient-specific T-cell reinvigoration and assessment of cell therapy product candidates in a cost-effective manner to expedite the preclinical product development process.